Close
Back to VSTM Stock Lookup

Verastem Oncology (VSTM) – PRNewswire

Apr 9, 2024 07:00 AM GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
Nov 22, 2021 07:30 AM Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer

Back to VSTM Stock Lookup